Skip to content

Assessment of Composite Inflammatory Ratios in Juvenile Idiopathic Arthritis and Their Association With Disease Activity

Assessment of Composite Inflammatory Ratios in Juvenile Idiopathic Arthritis and Their Association With Disease Activity

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07083466
Enrollment
90
Registered
2025-07-24
Start date
2025-07-15
Completion date
2026-04-15
Last updated
2025-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Idiopathic Arthritis

Brief summary

Juvenile Idiopathic Arthritis (JIA) is a prevalent pediatric rheumatic disorder characterized by persistent inflammation of one or more joints in children and adolescents. This chronic condition is a major contributor to both short- and long-term morbidity and functional disability We aim in this study to investigate the role of CAR, PLR, NLR ,systemic inflammatory index (SII ) and NAR ( SII and NAR have never been evaluated before in JIA patients ) as potential markers of disease activity in patients with non-systemic JIA (nsJIA) .

Interventions

DIAGNOSTIC_TESTcomplete blood count

blood test

DIAGNOSTIC_TESTserum albumin

blood test

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 16 Years
Healthy volunteers
Yes

Inclusion criteria

\- 1\. Patients who classified JIA according to International League of Associations for Rheumatology ILAR criteria on treatment with exclusion of systemic JIA. 2\. Patients with disease duration more than 6 months. 3. Age below 16 years old. 4. Patient cooperative and can answer questions. 5. Patients who are able and willing to give written informed consent or their parents/guardians

Exclusion criteria

* 1\. Systemic JIA. 2. Patients with other autoimmune or autoinflammatory diseases, immunodeficiencies, hematologic conditions, malignances and infectious disease at enrollment time or in the previous 2 weeks. Patients who are not able and willing to give written informed consent

Design outcomes

Primary

MeasureTime frame
possibility to use crp to albumin level as novel biomarker to predict disease activity in juvenile 0idiopathic arthritis6 months
possibility to detect systemic inflammatory index and its relation to disease activity and risk of flare in juvenile idiopathic arthritis6 months
assessment of activity of disease according to JDAS SCORE6 months
assessment of neutrophils to albumin ratio and its relation to JDAS score activity score6 months

Contacts

Primary ContactHadeer F Mohamed, resident
hadeer.fadl@med.sohag.edu.eg01030536331
Backup Contactosama S Daifallah, AssistantProf

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026